PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-09-14

Date Title Company
14-Sep-2023 MODERNA EXPANDS THE FIELD OF MRNA MEDICINE WITH POSITIVE CLINICAL RESULTS ACROSS CANCER, RARE DISEASE, AND INFECTIOUS DISEASE Moderna
14-Sep-2023 ABL Bio Taps into Synaffix ADC Technology to Accelerate Development of Bispecific ADC Products Synaffix B.V.,
14-Sep-2023 Stretch Marks Treatment Market: Unveiling Skin’s Potential, Poised to Surpass US$ 5.82 Billion by 2033 MARKITWIRED
14-Sep-2023 If you're happy and you know it... thank your genes. New genetic test reveals how predisposed to happiness we are. London Medical Laboratory
14-Sep-2023 Moderna Expands the Field of mRNA Medicine with Positive Clinical Results Across Cancer, Rare Disease, and Infectious Disease Moderna
14-Sep-2023 Skull Clamp Market: Fortifying Cranial Care, Set to Secure US$ 5.07 Billion Valuation by 2033 MARKITWIRED
14-Sep-2023 Autoimmune Disease Testing Market: Unlocking Opportunities on the Path to US$15.75 Billion by 2033 MARKITWIRED
14-Sep-2023 ELRIG UK Establishes Engagement Strategy Work Group ELRIG UK
14-Sep-2023 Uncomplicated Urinary Tract Infection Treatment Market: Empowering Wellness, Aiming for a US$ 17 Billion Valuation by 2033 MARKITWIRED
14-Sep-2023 Cerebral Oximetry Monitoring Market: Envisioning Clarity, Poised to Achieve a US$ 435.40 Million Valuation by 2033 MARKITWIRED
14-Sep-2023 Original-Research: HAEMATO AG (von GBC AG) HAEMATO AG
14-Sep-2023 Stereotactic Surgery Devices Market: Steering Surgical Precision, Navigating Towards a US$ 39.36 Billion Valuation by 2033 MARKITWIRED
14-Sep-2023 BRAIN Biotech AG: BRAIN Biotech AG’s Akribion Genomics technology receives patent approval for its groundbreaking nuclease G-dase E® BRAIN Biotech AG
14-Sep-2023 AlveoGene Launches to Develop Unique Inhaled Gene Therapies for Rare Respiratory Disorders AlveoGene
14-Sep-2023 Lundbeck presents clinical advances in migraine prevention with positive trial results at international headache congress H. Lundbeck A/S
14-Sep-2023 Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock Rocket Pharmaceuticals
14-Sep-2023 Rocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase 2 Trial Design for RP-A501 in Danon Disease RTW Biotech Opportunities Ltd
14-Sep-2023 ClinChoice Acquires CROMSOURCE, Expanding its Global Presence ClinChoice Medical Development
14-Sep-2023 Innate Pharma Reports First Half 2023 Financial Results and Business Update Businesswire
14-Sep-2023 Innate Pharma présente ses résultats financiers et l’avancée de son portefeuille au premier semestre 2023 Businesswire